Uma Rao, M.D.
Department of Pathology
West Wing Room 2.9
5230 Centre Avenue
Pittsburgh, PA 15235
Dr. Rao is the Reference Pathologist for the UPCI Melanoma Center.
Rao UN, Lee SJ, Luo W, Mihm MC Jr, Kirkwood JM (2010). Presence of tumor-infiltrating lymphocytes and a dominant nodule within primary melanoma are prognostic factors for relapse-free survival of patients with thick (t4) primary melanoma: pathologic analysis of the e1690 and e1694 intergroup trials. Am J Clin Pathol. 133: 646-653.
Wang W, Edington HD, Jukic DM, Rao UN, Land SR, Kirkwood JM (2008). Impact of IFNalpha2b upon pSTAT3 and the MEK/ERK MAPK pathway in melanoma. Cancer Immunol Immunother. 57: 1315-1321.
Wang W, Edington HD, Rao UN, Jukic DM, Wang H, Shipe-Spotloe JM, Kirkwood JM (2008). STAT3 as a biomarker of progression in atypical nevi of patients with melanoma: dose-response effects of systemic IFNalpha therapy. J Invest Dermatol. 128: 1997-2002.